Company page

Response Genetics Inc

Response Genetics Inc, trading under the ticker RGDXQ, is a public company based in the United States with a market capitalization of $77.59 million. The company specializes in providing genetic testing services to aid in the diagnosis and treatment of cancer. Its focus on precision medicine aims to improve patient outcomes through tailored therapies.